Indication

Acquired coagulation factor inhibitor disorder

An acquired coagulation factor inhibitor disorder is a rare, immune-mediated bleeding condition characterized by the spontaneous development of neutralizing autoantibodies directed against specific blood clotting factors. Read more about Acquired coagulation factor inhibitor disorder

1 drugs 1 manufacturers

Drugs that treat it

Common Acquired coagulation factor inhibitor disorder therapies.

Showing 1–1 of 1 drugs

Sort

NOVOSEVEN RT (coagulation factor VIIa (recombinant))

FACTOR VII·BLEEDING EPISODE IN HEMOPHILIA A·+6

NOVO NORDISK

Filter & compare in the drug finder →Opens the drug finder with Acquired coagulation factor inhibitor disorder preselected.

News & literature

Coming soon

Related codes

Coming soon

About Acquired coagulation factor inhibitor disorder.

Most frequently targeting factor VIII—known as acquired hemophilia A—these circulating inhibitors impair clotting activity, deplete targeted factor levels, and predominantly affect older adults, individuals with underlying autoimmune conditions or malignancies, and postpartum women.

Clinically, affected patients experience sudden, severe mucocutaneous bleeding, large intramuscular hematomas, and extensive soft tissue hemorrhage, presenting with an isolated prolonged clotting time that fails to correct upon mixing with normal plasma.

nih.gov
An acquired coagulation factor inhibitor disorder is a rare, immune-mediated bleeding condition characterized by the spontaneous development of neutralizing autoantibodies directed against specific blood clotting factors
b-s-h.org.uk
An acquired coagulation factor inhibitor disorder is a rare, immune-mediated bleeding condition characterized by the spontaneous development of neutralizing autoantibodies directed against specific blood clotting factors
rarediseases.org
Most frequently targeting factor VIII—known as acquired hemophilia A—these circulating inhibitors impair clotting activity, deplete targeted factor levels, and predominantly affect older adults, individuals with underlying autoimmune conditions or malignancies, and postpartum women Clinically, affected patients experience sudden, severe mucocutaneous bleeding, large intramuscular hematomas, and extensive soft tissue hemorrhage, presenting with an isolated prolonged clotting time that fails to co...
nih.gov
Most frequently targeting factor VIII—known as acquired hemophilia A—these circulating inhibitors impair clotting activity, deplete targeted factor levels, and predominantly affect older adults, individuals with underlying autoimmune conditions or malignancies, and postpartum women
wikipedia.org
Most frequently targeting factor VIII—known as acquired hemophilia A—these circulating inhibitors impair clotting activity, deplete targeted factor levels, and predominantly affect older adults, individuals with underlying autoimmune conditions or malignancies, and postpartum women
consultant360.com
Clinically, affected patients experience sudden, severe mucocutaneous bleeding, large intramuscular hematomas, and extensive soft tissue hemorrhage, presenting with an isolated prolonged clotting time that fails to correct upon mixing with normal plasma
haematologica.org
Clinically, affected patients experience sudden, severe mucocutaneous bleeding, large intramuscular hematomas, and extensive soft tissue hemorrhage, presenting with an isolated prolonged clotting time that fails to correct upon mixing with normal plasma

Personalize your experience

Follow Acquired coagulation factor inhibitor disorder and get updates as they land.

Create a free account

Already a member? Sign in

Follow an indication and get alerts when its drugs, labels, or guidelines change

Save any drug on this page to your favorites, synced across devices

AI-curated peer-reviewed research, summarized for your specialty

A morning digest of indication-relevant updates, when you want it